Aviva’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-62,431
Closed -$3.38M 876
2025
Q3
$3.38M Buy
62,431
+1,352
+2% +$77.3K 0.01% 618
2025
Q2
$3.36M Buy
61,079
+54,069
+771% +$3.18M 0.01% 615
2025
Q1
$496K Sell
7,010
-102
-1% -$6.86K ﹤0.01% 796
2024
Q4
$467K Hold
7,112
﹤0.01% 823
2024
Q3
$500K Sell
7,112
-5,509
-44% -$460K ﹤0.01% 809
2024
Q2
$1.04M Buy
12,621
+5,452
+76% +$454K ﹤0.01% 642
2024
Q1
$626K Buy
7,169
+181
+3% +$16.2K ﹤0.01% 827
2023
Q4
$674K Sell
6,988
-33
-0.5% -$2.92K ﹤0.01% 754
2023
Q3
$621K Sell
7,021
-19,779
-74% -$1.76M ﹤0.01% 749
2023
Q2
$2.32M Buy
26,800
+17,506
+188% +$1.65M 0.01% 606
2023
Q1
$904K Sell
9,294
-55,771
-86% -$5.78M ﹤0.01% 867
2022
Q4
$6.73M Buy
65,065
+38,415
+144% +$3.61M 0.03% 525
2022
Q3
$2.26M Sell
26,650
-8,200
-24% -$730K 0.01% 688
2022
Q2
$2.89M Sell
34,850
-1,183
-3% -$94.2K 0.02% 694
2022
Q1
$2.78M Sell
36,033
-18,491
-34% -$1.55M 0.01% 719
2021
Q4
$4.82M Sell
54,524
-1,309
-2% -$108K 0.02% 593
2021
Q3
$4.32M Sell
55,833
-2,774
-5% -$219K 0.02% 611
2021
Q2
$4.89M Sell
58,607
-2,375
-4% -$188K 0.02% 598
2021
Q1
$4.61M Sell
60,982
-503
-0.8% -$41.1K 0.02% 553
2020
Q4
$5.39M Buy
61,485
+3,201
+5% +$254K 0.03% 484
2020
Q3
$4.43M Sell
58,284
-20,155
-26% -$2.04M 0.03% 477
2020
Q2
$9.68M Sell
78,439
-29,308
-27% -$2.91M 0.06% 278
2020
Q1
$9.11M Buy
107,747
+20,852
+24% +$1.8M 0.07% 257
2019
Q4
$7.35M Buy
86,895
+23,669
+37% +$1.79M 0.04% 354
2019
Q3
$4.26M Sell
63,226
-2,069
-3% -$159K 0.03% 468
2019
Q2
$5.59M Sell
65,295
-1,372
-2% -$117K 0.04% 415
2019
Q1
$5.92M Buy
66,667
+447
+0.7% +$41.4K 0.04% 403
2018
Q4
$5.64M Sell
66,220
-18,574
-22% -$1.77M 0.04% 382
2018
Q3
$8.22M Sell
84,794
-3,019
-3% -$301K 0.05% 377
2018
Q2
$8.27M Sell
87,813
-1,291
-1% -$113K 0.05% 362
2018
Q1
$7.22M Sell
89,104
-8,141
-8% -$699K 0.04% 395
2017
Q4
$8.67M Sell
97,245
-11,585
-11% -$1.01M 0.05% 372
2017
Q3
$10.1M Buy
108,830
+2,480
+2% +$219K 0.05% 344
2017
Q2
$9.66M Buy
106,350
+2,310
+2% +$210K 0.05% 358
2017
Q1
$9.13M Sell
104,040
-5,342
-5% -$475K 0.05% 360
2016
Q4
$9.06M Buy
109,382
+6,931
+7% +$596K 0.05% 368
2016
Q3
$9.48M Buy
102,451
+8,373
+9% +$788K 0.06% 352
2016
Q2
$7.32M Buy
94,078
+15,231
+19% +$1.29M 0.05% 387
2016
Q1
$6.5M Buy
78,847
+924
+1% +$75.2K 0.05% 404
2015
Q4
$8.16M Sell
77,923
-263
-0.3% -$27.5K 0.06% 336
2015
Q3
$8.23M Sell
78,186
-1,960
-2% -$262K 0.07% 309
2015
Q2
$11M Sell
80,146
-1,410
-2% -$175K 0.08% 281
2015
Q1
$10.2M Buy
81,556
+24,623
+43% +$2.61M 0.07% 325
2014
Q4
$5.15M Buy
56,933
+160
+0.3% +$13.3K 0.04% 461
2014
Q3
$4.1M Buy
56,773
+210
+0.4% +$13.8K 0.03% 543
2014
Q2
$3.52M Buy
56,563
+2,720
+5% +$164K 0.03% 598
2014
Q1
$3.67M Buy
+53,843
New +$3.97M 0.03% 554

Other funds holding BMRN